Literature DB >> 28339964

Treatment strategy and IDH status improve nomogram validity in newly diagnosed GBM patients.

Wen Cheng1, Chuanbao Zhang2, Xiufang Ren3, Zheng Wang2, Xing Liu2, Sheng Han1, Anhua Wu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28339964      PMCID： PMC5464430          DOI： 10.1093/neuonc/nox012

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  8 in total

Review 1.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

Review 2.  Nomograms in oncology: more than meets the eye.

Authors:  Vinod P Balachandran; Mithat Gonen; J Joshua Smith; Ronald P DeMatteo
Journal:  Lancet Oncol       Date:  2015-04       Impact factor: 41.316

Review 3.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

4.  CGCG clinical practice guidelines for the management of adult diffuse gliomas.

Authors:  Tao Jiang; Ying Mao; Wenbin Ma; Qing Mao; Yongping You; Xuejun Yang; Chuanlu Jiang; Chunsheng Kang; Xuejun Li; Ling Chen; Xiaoguang Qiu; Weimin Wang; Wenbin Li; Yu Yao; Shaowu Li; Shouwei Li; Anhua Wu; Ke Sai; Hongmin Bai; Guilin Li; Baoshi Chen; Kun Yao; Xinting Wei; Xianzhi Liu; Zhiwen Zhang; Yiwu Dai; Shengqing Lv; Liang Wang; Zhixiong Lin; Jun Dong; Guozheng Xu; Xiaodong Ma; Jinquan Cai; Wei Zhang; Hongjun Wang; Lingchao Chen; Chuanbao Zhang; Pei Yang; Wei Yan; Zhixiong Liu; Huimin Hu; Jing Chen; Yuqing Liu; Yuan Yang; Zheng Wang; Zhiliang Wang; Yongzhi Wang; Gan You; Lei Han; Zhaoshi Bao; Yanwei Liu; Yinyan Wang; Xing Fan; Shuai Liu; Xing Liu; Yu Wang; Qixue Wang
Journal:  Cancer Lett       Date:  2016-03-07       Impact factor: 8.679

5.  An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.

Authors:  Haley Gittleman; Daniel Lim; Michael W Kattan; Arnab Chakravarti; Mark R Gilbert; Andrew B Lassman; Simon S Lo; Mitchell Machtay; Andrew E Sloan; Erik P Sulman; Devin Tian; Michael A Vogelbaum; Tony J C Wang; Marta Penas-Prado; Emad Youssef; Deborah T Blumenthal; Peixin Zhang; Minesh P Mehta; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2017-05-01       Impact factor: 12.300

6.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

7.  MGMT gene silencing and benefit from temozolomide in glioblastoma.

Authors:  Monika E Hegi; Annie-Claire Diserens; Thierry Gorlia; Marie-France Hamou; Nicolas de Tribolet; Michael Weller; Johan M Kros; Johannes A Hainfellner; Warren Mason; Luigi Mariani; Jacoline E C Bromberg; Peter Hau; René O Mirimanoff; J Gregory Cairncross; Robert C Janzer; Roger Stupp
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

8.  IDH1 and IDH2 mutations in gliomas.

Authors:  Hai Yan; D Williams Parsons; Genglin Jin; Roger McLendon; B Ahmed Rasheed; Weishi Yuan; Ivan Kos; Ines Batinic-Haberle; Siân Jones; Gregory J Riggins; Henry Friedman; Allan Friedman; David Reardon; James Herndon; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein; Darell D Bigner
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 176.079
  8 in total
  9 in total

1.  A prognostic nomogram for patients with newly diagnosed adult thalamic glioma in a surgical cohort.

Authors:  Xiaodong Niu; Yuan Yang; Xingwang Zhou; Haodongfang Zhang; Yuekang Zhang; Yanhui Liu; Qing Mao
Journal:  Neuro Oncol       Date:  2021-02-25       Impact factor: 12.300

2.  A Glioblastoma Genomics Primer for Clinicians.

Authors:  John D Patterson; Thidathip Wongsurawat; Analiz Rodriguez
Journal:  Med Res Arch       Date:  2020-02-21

3.  Optimizing management of the elderly patient with glioblastoma: Survival prediction online tool based on BC Cancer Registry real-world data.

Authors:  Rachel Zhao; Jonathan Zeng; Kimberly DeVries; Ryan Proulx; Andra Valentina Krauze
Journal:  Neurooncol Adv       Date:  2022-04-13

4.  GLIMPSE: a glioblastoma prognostication model using ensemble learning-a surveillance, epidemiology, and end results study.

Authors:  Kamel A Samara; Zaher Al Aghbari; Amani Abusafia
Journal:  Health Inf Sci Syst       Date:  2021-01-12

5.  A Multiparametric MRI-Based Radiomics Nomogram for Preoperative Prediction of Survival Stratification in Glioblastoma Patients With Standard Treatment.

Authors:  Xin Jia; Yixuan Zhai; Dixiang Song; Yiming Wang; Shuxin Wei; Fengdong Yang; Xinting Wei
Journal:  Front Oncol       Date:  2022-02-16       Impact factor: 6.244

6.  Multiple Survival Outcome Prediction of Glioblastoma Patients Based on Multiparametric MRI.

Authors:  Bin Wang; Shan Zhang; Xubin Wu; Ying Li; Yueming Yan; Lili Liu; Jie Xiang; Dandan Li; Ting Yan
Journal:  Front Oncol       Date:  2021-11-25       Impact factor: 6.244

7.  Comparative profiling of immune genes improves the prognoses of lower grade gliomas.

Authors:  Zhiliang Wang; Wen Cheng; Zheng Zhao; Zheng Wang; Chuanbao Zhang; Guanzhang Li; Anhua Wu; Tao Jiang
Journal:  Cancer Biol Med       Date:  2021-10-09       Impact factor: 5.347

8.  A Comparison Study of Machine Learning (Random Survival Forest) and Classic Statistic (Cox Proportional Hazards) for Predicting Progression in High-Grade Glioma after Proton and Carbon Ion Radiotherapy.

Authors:  Xianxin Qiu; Jing Gao; Jing Yang; Jiyi Hu; Weixu Hu; Lin Kong; Jiade J Lu
Journal:  Front Oncol       Date:  2020-10-30       Impact factor: 6.244

9.  DNA Methylation-Driven Genes for Developing Survival Nomogram for Low-Grade Glioma.

Authors:  Yingyun Guo; Yuan Li; Jiao Li; Weiping Tao; Weiguo Dong
Journal:  Front Oncol       Date:  2022-01-17       Impact factor: 6.244
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.